What is the official website of Novartis Science ?

The official website of Novartis Science is https://www.novartis.com/research-development.

What is Novartis Science's cybersecurity risk score?

Novartis Science has an AI-generated cybersecurity risk score of 752 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has Novartis Science experienced?

According to Rankiteo, Novartis Science currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Novartis Science been affected by any supply chain cyber incidents ?

According to Rankiteo, Novartis Science has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Novartis Science have SOC 2 Type 1 certification ?

According to Rankiteo, Novartis Science is not certified under SOC 2 Type 1.

Does Novartis Science have SOC 2 Type 2 certification ?

According to Rankiteo, Novartis Science does not hold a SOC 2 Type 2 certification.

Does Novartis Science comply with GDPR ?

According to Rankiteo, Novartis Science is not listed as GDPR compliant.

Does Novartis Science have PCI DSS certification ?

According to Rankiteo, Novartis Science does not currently maintain PCI DSS compliance.

Does Novartis Science comply with HIPAA ?

According to Rankiteo, Novartis Science is not compliant with HIPAA regulations.

Does Novartis Science have ISO 27001 certification ?

According to Rankiteo,Novartis Science is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Novartis Science operate in ?

Novartis Science operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does Novartis Science have ?

Novartis Science employs approximately 18 people worldwide.

Does Novartis Science own any subsidiaries ?

Novartis Science presently has no subsidiaries across any sectors.

How many LinkedIn followers does Novartis Science have ?

Novartis Science's official LinkedIn profile has approximately 220,678 followers.

What is the NAICS classification code for Novartis Science ?

Novartis Science is classified under the NAICS code 3254, which corresponds to Pharmaceutical and Medicine Manufacturing.

Does Novartis Science have a Crunchbase profile ?

No, Novartis Science does not have a profile on Crunchbase.

Does Novartis Science have a LinkedIn profile ?

Yes, Novartis Science maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/novartis-science.

How many cybersecurity incidents has Novartis Science experienced ?

As of September 28, 2026, Rankiteo reports that Novartis Science has experienced 2 cybersecurity incidents.

How many peer or competitor companies does Novartis Science have ?

Novartis Science has an estimated 5,770 peer or competitor companies worldwide.

What types of cybersecurity incidents has Novartis Science faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach and Cyber Attack.

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

Novartis Science

Boost Score +25 with badge (5 left)

752

/1000

Fair

777

/1000

Fair

Novartis Science Vendor Cyber Rating & Cyber Score

novartis.com

Add Your Compliance Badge

Novartis is an innovative medicines company with research and development at its core. Our R&D engine powers an industry-leading pipeline dedicated to delivering transformative medicines to fight disease, restore possibilities and help people live life on their own terms. See our community guidelines: https://go.novartis.social/4bqbjuA

Novartis Science

Novartis Science CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

Novartis

Breach

2/2026

NOV1774449180

Novartis Science

Cyber Attack

100

06/2022

NOV21267722

Loading…

A.I.

Novartis Science Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for Novartis Science

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Science in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Novartis Science in 2026.

Incident Types Novartis Science vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for Novartis Science in 2026.

Incident History - Novartis Science (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Novartis Science Subsidiaries

Novartis Science

Pharmaceutical Manufacturing

Website: https://www.novartis.com/research-development

Company Size: 18

NovartisPharmaceutical Manufacturing

Novartis IndiaPharmaceutical Manufacturing

Novartis BeluxPharmaceutical Manufacturing

Novartis NorgePharmaceutical Manufacturing

Novartis DanmarkPharmaceutical Manufacturing

Loading…

Novartis Science Similar Companies

Takeda

cb takeda.com

We strive to transform lives. While the science we advance is constantly evolving, our core purpose is enduring. For more than two centuries, our values have guided us to do what’s right for patients and for society. We know that changing lives requires us to do things differently. We start by listening to and addressing what really matters to patients, the people who love them, and those in the healthcare system who provide care. And that’s what inspires us all to be bold, push boundaries and set new standards that open up greater opportunities. Read our community guidelines: https://takeda.info/communityguidelines

SUN PHARMA

sunpharma.com

Sun Pharma is the world's fourth-largest speciality generic pharmaceutical company and No. 1 in India. We provide high-quality, affordable medicines trusted by customers and patients in over 100 countries. Sun Pharma's global presence is supported by more than 40 manufacturing facilities spread across 5 continents, R&D centres across the globe, and a multicultural workforce comprising over 50 nationalities. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising around 3,000 scientists and R&D investments of over 6-8% of annual revenues. At Sun, our people are our greatest asset. Ours has never been a story of individual brilliance but of cultivating a culture of realising collective potential. In our journey, everyone is enabled to take charge in an environment that offers limitless growth opportunities. We are with you every step of the way, so you can shine for years to come. With the launch of our Employee Value Proposition (EVP), we define our promise to ‘Create Your Own Sunshine'—driven by the three pillars of Better Every Day, Take Charge, and Thrive Together. These pillars drive progress at Sun so that people can achieve what they would have thought impossible. Learn more about our EVP here: https://sunpharma.com/careers/

Novartis

novartis.com

Novartis is an innovative medicines company. Every day, working to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide. Find out more at https://www.novartis.com See our community guidelines: https://go.novartis.social/3Nboxki

PT Kalbe Farma, Tbk

kalbe.co.id

Established in 1966, PT Kalbe Farma Tbk. (“the Company” or “Kalbe”) has gone a long way from its humble beginnings as a garage-operated pharmaceutical business in North Jakarta. It has expanded by strategic acquisitions of pharmaceutical companies, building a leading brand positioning and reaching to international markets to transform itself into an integrated consumer health and nutrition enterprise to promote its mission to improve health for a better life. Kalbe expands its business interests and transformed itself to become a provider of an integrated healthcare solution through its 4 business divisions: the Prescription Pharmaceutical Division, Consumer Health Division, Nutritionals Division and Distribution and Logistics Division. These business divisions manage an extensive portfolio of prescription pharmaceuticals and OTC drugs, energy drink and nutrition products, as well as a robust distribution arm serving over one million outlets across Indonesia’s vast archipelago. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market. Kalbe Farma has established a robust research and development activities in leading edge generic drug formulation and continuous development of innovative consumer and nutritional products. Through strategic alliances with international partners, Kalbe have also started to support several successful research and development venture working on cancer drugs, stem cells and biotechnology research. With 17,000 employees, Kalbe Farma is the largest healthcare provider in Indonesia, with unrivaled marketing, branding, distribution, financial strength and research and development expertise. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71.0 trillion and sales turnover Rp21.0 trillion by end of 2018.

Johnson & Johnson Innovative Medicine

jnj.com

At Johnson & Johnson Innovative Medicine, we innovate with purpose, to lead where medicine is going. The experiences of patients around the world inform and inspire our science-based innovations, which continue to change and save lives. Applying rigorous science with compassion, we confidently address the most complex diseases of our time and develop the potential medicines of tomorrow. We are continuously working to develop treatments, aspiring to find cures, pioneering the path from lab to life, and championing patients every step of the way. https://bit.ly/3reuMvK

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Zydus Group

zyduslife.com

The Zydus Group with an overarching purpose of empowering people with freedom to live healthier and more fulfilled lives, is an innovative, global life-sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies. The group employs over 27000 people worldwide and is driven by its mission to unlock new possibilities in life-sciences through quality healthcare solutions that impact lives. The group aspires to transform lives through pathbreaking discoveries.

Novo Nordisk

cb novonordisk.com

We’re not your typical healthcare company. In a modern world of quick fixes, we focus on solutions to defeat serious chronic disease and create long-term health. We seek out new ideas and put people first as we push the boundaries of science, make healthcare more accessible, and work to treat, prevent, and even cure diseases that affect millions of lives. Founded in Denmark in 1923, today we employ more than 68,800 people in 80 offices around the world – all united by our bold purpose to drive change to defeat serious chronic diseases. Want to learn more? Visit www.novonordisk.com. This page isn’t intended for discussions about products. As such, postings or comments that contain product discussions may be removed. This page is for discussions about Novo Nordisk and its subsidiaries and the initiatives and projects we are involved in. While we welcome everyone to make comments, we reserve the right to block and remove those that are off-topic, abusive or intended to spam. Any questions specific to products should be made to your healthcare professional. If you wish to file an adverse drug reaction please contact Novo Nordisk’s office in the country you live in: https://www.novonordisk.com/contact-us/find-local-information.html For other customer complaints, please contact us here: https://www.novonordisk.com/contact-us.html Please keep in mind that Novo Nordisk A/S and its subsidiaries work within a highly regulated industry. Therefore, comments that pertain to legal matters or regulatory issues may be removed. Comments contained on this site come from members of the public, and do not necessarily reflect the views of Novo Nordisk A/S. Novo Nordisk A/S does not endorse or approve any content added by other LinkedIn users. Learn more about our privacy disclaimer and community guidelines here: https://www.novonordisk.com/data-privacy-and-user-rights/social-media-privacy-disclaimer.html

Loading…

NEWS

Novartis Science CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

February 08, 2026 08:00 AM

Your money online is at risk: UAE’s Cyber Security Council issues warning

The council stressed that steps taken to safeguard personal and financial data across cyberspace reduces the risk of falling victim to cyber...

Read Article

December 17, 2025 08:00 AM

Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

SAN FRANCISCO, December 17, 2025--Salesforce (NYSE: CRM), the world's #1 AI CRM, announced today that Novartis (NYSE: NVS), a leading global...

Read Article

May 20, 2025 07:00 AM

Women Know Cyber: 150 Fascinating Females Fighting Cybercrime

Role models for students, parents, educators, and the cybersecurity community Sponsored by Secureworks.

Read Article

March 03, 2025 08:00 AM

February M&A deals: Thermo Fisher, Novartis, and CyberArk Software

Thermo Fisher Scientific Inc. struck a deal with Minnesota-based health care company, Solventum, to buy its purification and filtration business for about $4.1...

Read Article

February 16, 2025 08:00 AM

Ranking the Top 10 High-Paying Tech Jobs in Switzerland in 2025

Explore the top 10 high-paying tech jobs in Switzerland for 2025, including AI, cybersecurity, and cloud computing roles, offering lucrative...

Read Article

December 23, 2024 08:00 AM

Ranking the Top 10 High-Paying Tech Jobs in Switzerland

The Swiss tech industry is thriving, with high demand for roles like Chief Information Officer, Cloud Solutions Architect,...

Read Article

December 23, 2024 08:00 AM

Top 10 Tech Internships Offered in Switzerland

Discover the top 10 tech internships in Switzerland, from Google to Novartis. Learn about opportunities, application tips, and benefits for...

Read Article

October 17, 2024 07:00 AM

Brave new world: Building Europe’s capacities for defence and security R&D

For the first time since the end of the Cold War, the next period of EU politics and policy-making will be dominated by security issues.

Read Article

July 19, 2024 07:00 AM

Pharma companies report various levels of exposure to IT outage caused by CrowdStrike, Microsoft

While the international IT outage caused by cybersecurity specialist CrowdStrike—and subsequently Microsoft—has grounded airlines and forced...

Read Article

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-96284

SUMMARY

A malicious user can get read-access to files in the flatpak-system-helper context if a system OCI repository is configured, because the OCI code paths in the system helper follow symlinks when importing OCI images that are under the user's control.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 2.5)

cvss3

Base Score: 2.5

Complexity: HIGH

CVSS:3.1/AV:L/AC:H/PR:L/UI:N/S:U/C:L/I:N/A:N

Impact Score

1.4

Exploitability

REFERENCES

CVE-2026-100886

SUMMARY

A vulnerability was identified in Seetong T8108, T8108P, T8116 and T8232 4.6.1.4-build202604241011. The affected element is an unknown function of the component Debug Service. Such manipulation leads to improper authentication. The attack may be launched remotely. The exploit is publicly available and might be used. The vendor was contacted early about this disclosure but did not respond in any way.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 10)

cvss2

Base Score: 10.0

Complexity: LOW

AV:N/AC:L/Au:N/C:C/I:C/A:C

cvss3

Base Score: 10.0

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:C/C:H/I:H/A:H

cvss4

Base Score: 9.3

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:H/VI:H/VA:H/SC:H/SI:H/SA:H/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

3.9

REFERENCES

CVE-2026-100885

SUMMARY

A vulnerability was found in Krayin laravel-crm up to 2.2.4. This affects an unknown function of the file packages/Webkul/Installer/src/Http/Middleware/CanInstall.php of the component admin-config-setup API Endpoint. The manipulation results in authorization bypass. The attack may be launched remotely. The exploit has been made public and could be used. Upgrading to version 2.2.5 mitigates this issue. The patch is identified as 89f2916b6a46ff91bd1999ce38158fa0de8b9490. Upgrading the affected component is recommended.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 7.3)

cvss2

Base Score: 7.5

Complexity: LOW

AV:N/AC:L/Au:N/C:P/I:P/A:P

cvss3

Base Score: 7.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 5.5

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

3.9

REFERENCES

CVE-2026-100884

SUMMARY

A vulnerability has been found in Krayin laravel-crm up to 2.2.5. The impacted element is the function Storage::download of the file packages/Webkul/Admin/src/Config/acl.php of the component attachment-download Endpoint. The manipulation of the argument ID leads to improper control of resource identifiers. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. Upgrading to version 2.2.6 is sufficient to resolve this issue. The identifier of the patch is 13d6988cda8d69ece45ee1890effc90a7f21cdc1. It is suggested to upgrade the affected component.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 4.3)

cvss2

Base Score: 4.0

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:N/A:N

cvss3

Base Score: 4.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:N/A:N

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

1.4

Exploitability

2.8

REFERENCES

CVE-2026-100883

SUMMARY

A flaw has been found in Krayin laravel-crm up to 2.2.5. The affected element is an unknown function of the file packages/Webkul/Admin/src/Config/acl.php. Executing a manipulation can lead to improper access controls. The attack can be launched remotely. The exploit has been published and may be used. Upgrading to version 2.2.6 is sufficient to fix this issue. This patch is called a399404a388d8ad2700a01349d0d98069c8e85a4. The affected component should be upgraded.

Published

Date2026-09-27

Updated

Date2026-09-27

RISK INFORMATION (Score: 6.3)

cvss2

Base Score: 6.5

Complexity: LOW

AV:N/AC:L/Au:S/C:P/I:P/A:P

cvss3

Base Score: 6.3

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:L

cvss4

Base Score: 2.1

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:L/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

3.4

Exploitability

2.8

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…

Badge your company to reduce your risk score and your cyber insurance costs!

Trusted by insurers. Chosen by leaders.

Novartis Science Vendor Cyber Rating & Cyber Score

Novartis Science A.I CyberSecurity Scoring

Novartis Science CyberSecurity News & History

Novartis Science Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Novartis Science

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Novartis Science vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Novartis Science (X = Date, Y = Severity)

Novartis Science Subsidiaries

Novartis Science

Novartis Science Similar Companies

Takeda

SUN PHARMA

Novartis

PT Kalbe Farma, Tbk

Johnson & Johnson Innovative Medicine

Alembic Pharmaceuticals Limited

MANKIND PHARMA LTD

Zydus Group

Novo Nordisk

Novartis Science CyberSecurity News

Your money online is at risk: UAE’s Cyber Security Council issues warning

Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

Women Know Cyber: 150 Fascinating Females Fighting Cybercrime

February M&A deals: Thermo Fisher, Novartis, and CyberArk Software

Ranking the Top 10 High-Paying Tech Jobs in Switzerland in 2025

Ranking the Top 10 High-Paying Tech Jobs in Switzerland

Top 10 Tech Internships Offered in Switzerland

Brave new world: Building Europe’s capacities for defence and security R&D

Pharma companies report various levels of exposure to IT outage caused by CrowdStrike, Microsoft

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo

Novartis Science CyberSecurity News & History

Novartis Science Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Incident Predictions locked

A.I Risk Score Likelihood 3 - 6 - 9 months

A.I. Risk Score Predictions locked

Underwriter Stats for Novartis Science

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incidents vs All-Companies Average (This Year)

Incident Types Novartis Science vs Pharmaceutical Manufacturing Industry Avg (This Year)

Incident History - Novartis Science (X = Date, Y = Severity)

Novartis Science Subsidiaries

Novartis Science

Novartis Science Similar Companies

Takeda

SUN PHARMA

Novartis

PT Kalbe Farma, Tbk

Johnson & Johnson Innovative Medicine

Alembic Pharmaceuticals Limited

MANKIND PHARMA LTD

Zydus Group

Novo Nordisk

Novartis Science CyberSecurity News

Your money online is at risk: UAE’s Cyber Security Council issues warning

Salesforce’s Agentforce Life Sciences Selected by Novartis to Drive More Personalized Customer Engagement Globally

Women Know Cyber: 150 Fascinating Females Fighting Cybercrime

February M&A deals: Thermo Fisher, Novartis, and CyberArk Software

Ranking the Top 10 High-Paying Tech Jobs in Switzerland in 2025

Ranking the Top 10 High-Paying Tech Jobs in Switzerland

Top 10 Tech Internships Offered in Switzerland

Brave new world: Building Europe’s capacities for defence and security R&D

Pharma companies report various levels of exposure to IT outage caused by CrowdStrike, Microsoft

Global CVEs (Not Company-Specific)

Access Data Using Our API

What Do We Measure ?

These are some of the factors we use to calculate the overall score:

Rankiteo